Clinical AI Shifts From Benchmarks to Peer-Reviewed Trials
Medical AI claims increasingly have to clear prospective peer-reviewed clinical study designs rather than retrospective benchmarks, so expect labs to fund registered trials with named hospital partners and procurement to follow published evidence rather than leaderboards.
forming · confidence 40 · Emerging (watchlist) · tracking since October 26, 2026 · updated October 26, 2026
Why the conviction moved
- Oct 26Strengthened +5
A study in The Lancet found Google's AMIE matched physicians' final diagnoses 90% of the time across 98 real patient consultations. Every conversation was monitored live by a board-certified internist, and none met the criteria for stopping it, which is the shift from benchmarks to peer-reviewed prospective evidence this thesis predicts.
Source trail
Supporting · October 26, 2026
A Lancet study found Google's AMIE matched physicians' final diagnoses 90% of the time across 98 patient consultations
A study in The Lancet found Google's AMIE matched physicians' final diagnoses 90% of the time across 98 real patient consultations. Every conversation was monitored live by a board-certified internist, and none met the criteria for stopping it, which is the shift from benchmarks to peer-reviewed prospective evidence this thesis predicts.
Google Research
Unlock full source trail, score history, and daily updates.
Unlock TrendsTownsquare
Argue the thesis in Townsquare.